Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Lamphere

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Medical Anthropology Quarterly|February 28, 2001
Comments on the Navajo Healing ProjectL Lamphere
Pediatric Nursing|July 1, 1978
Whatever happened to sulphur and molasses?L L Lamphere
Endocrinology|November 1, 1992
Components of signaling pathways for insulin and insulin-like growth factor-I in muscle myoblasts and myotubesL Lamphere, G E Lienhard
Wisconsin Medical Journal|March 1, 1972
Double rupture of the heartL G Crocker, W Storms, R L Lamphere
Molecular Reproduction and Development|August 1, 1993
Insulin and IGF-I signaling through the insulin receptor substrate 1S R Keller, L Lamphere, B E Lavan, et al.
The American Journal of Physiology|March 1, 1994
Activation of PI 3-kinase in 3T3-L1 adipocytes by association with insulin receptor substrate-1L Lamphere, C L Carpenter, Z F Sheng, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 30, 2000
Novel chimeric p16 and p27 molecules with increased antiproliferative activity for vascular disease gene therapyL Lamphere, L Tsui, S Wick, et al.
Oncogene|April 24, 1997
Interaction between Cdc37 and Cdk4 in human cellsL Lamphere, F Fiore, X Xu, et al.
Biochemistry|August 16, 1994
Potent activation of phosphatidylinositol 3'-kinase by simple phosphotyrosine peptides derived from insulin receptor substrate 1 containing two YMXM motifs for binding SH2 domainsJ J Herbst, G Andrews, L Contillo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 13, 2001
p27-p16 Chimera: a superior antiproliferative for the prevention of neointimal hyperplasiaJ G McArthur, H Qian, D Citron, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Medical Anthropology Quarterly|February 28, 2001
Comments on the Navajo Healing ProjectL Lamphere
Pediatric Nursing|July 1, 1978
Whatever happened to sulphur and molasses?L L Lamphere
Endocrinology|November 1, 1992
Components of signaling pathways for insulin and insulin-like growth factor-I in muscle myoblasts and myotubesL Lamphere, G E Lienhard
Wisconsin Medical Journal|March 1, 1972
Double rupture of the heartL G Crocker, W Storms, R L Lamphere
Molecular Reproduction and Development|August 1, 1993
Insulin and IGF-I signaling through the insulin receptor substrate 1S R Keller, L Lamphere, B E Lavan, et al.
The American Journal of Physiology|March 1, 1994
Activation of PI 3-kinase in 3T3-L1 adipocytes by association with insulin receptor substrate-1L Lamphere, C L Carpenter, Z F Sheng, et al.
Journal of Molecular Medicine (Berlin, Germany)|November 30, 2000
Novel chimeric p16 and p27 molecules with increased antiproliferative activity for vascular disease gene therapyL Lamphere, L Tsui, S Wick, et al.
Oncogene|April 24, 1997
Interaction between Cdc37 and Cdk4 in human cellsL Lamphere, F Fiore, X Xu, et al.
Biochemistry|August 16, 1994
Potent activation of phosphatidylinositol 3'-kinase by simple phosphotyrosine peptides derived from insulin receptor substrate 1 containing two YMXM motifs for binding SH2 domainsJ J Herbst, G Andrews, L Contillo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 13, 2001
p27-p16 Chimera: a superior antiproliferative for the prevention of neointimal hyperplasiaJ G McArthur, H Qian, D Citron, et al.
Pageof 2